IP Verse

Corticosteroids For The Treatment Of Inflammatory Diseases Of The Gastrointestinal Tract - EP2328553

The patent EP2328553 was granted to The Regents OF The University OF California on Jun 10, 2020. The application was originally filed on Nov 12, 2008 under application number EP08876449A. The patent is currently recorded with a legal status of "Revoked".

EP2328553

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Application Number
EP08876449A
Filing Date
Nov 12, 2008
Status
Revoked
Sep 2, 2022
Publication Date
Jun 10, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

AECHTERMar 10, 2021TER MEER STEINMEISTER & PARTNER -

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP1201242
INTERNATIONAL-SEARCH-REPORTUS2006013873
INTERNATIONAL-SEARCH-REPORTUS2007031459
INTERNATIONAL-SEARCH-REPORTUS5863910
INTERNATIONAL-SEARCH-REPORTWO2006099591
INTERNATIONAL-SEARCH-REPORTWO9932156
OPPOSITIONUS2007111978

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- ACEVES S S ET AL, "Topical viscous budesonide suspension for treatment of eosinophilic esophagitis", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 116, no. 3, ISSN 0091-6749, (20050901), pages 705 - 706, (20050911), XP026968506
INTERNATIONAL-SEARCH-REPORT- Rowe eta al., Handbook of Pharmaceutical Excipients, Pharmaceutical Press, (20060101), pages 442 - 445, XP002530885 [Y] 6,13-15 * the whole document *
OPPOSITION- "Pulmicort Respules (budesonide inhalation suspension) 0.25 mg and 0.5 mg", accessdata.fda.gov, (20000000), pages 1 - 17, XP055789218
OPPOSITION- ROWE Raymond C. et al., "Maltodextrin", Handbook of Pharmaceutical Excipients, (20060000), pages 442 - 444, XP055738279
OPPOSITION- SUKLJE, Helena, "Results of Experiments linked to Opposition against EP 2328553 B1 for assessing the viscosity of compositions containing a mixture of various Maltodextrins with saline and Splenda with Saline", (20210302), pages 1 - 1, XP055789219
OPPOSITION- DOKIC et al., "Relation between Viscous Characteristics and Dextrose Equivalent of Maltodextrins", Starch/Starke, (20040000), vol. 56, doi:10.1002/star.200400294, pages 520 - 525, XP001210542
OPPOSITION- ACEVES S. et al., "Topical viscous budesonide suspension for treatment of eosinophilic esophagitis", J. Allergy Clin Immunol, (20050000), vol. 116, no. 3, doi:10.1016/j.jaci.2005.05.011, pages 705 - 706, XP005068207
OPPOSITION- VAGHI A . et al., "In vitro comparison of nebulised budesonide (Pulmicort Respules) and beclomethasone dipropionate (Clenil per Aerosol", Pulm Pharmacol Ther, (20041220), vol. 18, no. 2, doi:10.1016/j.pupt.2004.10.004, pages 151 - 3, XP004706668
OPPOSITION- HANKO et al., "Determination of Sucralose in Splenda and a Sugar-Free Beverage Using High-Performance Anion-Exchange Chromatography with Pulsed Amperomet- ric Detection.", J. Agric. Food Chem., (20040000), vol. 52, pages 4375 - 4379, XP055671568

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents